
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Newer Antipsychotic Medications: Discussions
Advertisement
Articles in this issue
almost 29 years ago
Introduction: Looking Beyond the Formulary Budgetalmost 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsalmost 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisalmost 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomealmost 29 years ago
Bibliographyalmost 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Detailed Liver Atlas Links Macrophage Activity to MASH Progression
3
CheckMate 9LA at 6 Years Shows Enduring Benefits From Dual Immunotherapy Plus Chemotherapy in Metastatic NSCLC
4
Value-Based Care Needs a Rebrand. Will 2026 Be the Year It Finally Gets One?
5




























































